The Net Margin of Intra-Cellular Therapies Inc (ITCI) is -10.97%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -10.97% |
2023-12-31 | -30.08% |
2022-12-31 | -102.40% |
2021-12-31 | -339.02% |
2020-12-31 | -995.61% |
2019-12-31 | -147700.00% |
2018-12-31 | -48900.00% |
2017-12-31 | -38800.00% |
2016-12-31 | -104800.00% |